Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Crohn disease"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1063
Tytuł:
Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot study.
Autorzy:
Arkenbosch JHC; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Ruler O; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
Dwarkasing RS; Department of Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Fuhler GM; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Schouten WR; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.
van Oud-Alblas MB; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.
de Graaf EJR; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.
de Vries AC; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 783-791. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:
Journal Article
MeSH Terms:
Crohn Disease*/complications
Crohn Disease*/surgery
Rectal Fistula*/diagnostic imaging
Rectal Fistula*/etiology
Rectal Fistula*/surgery
Platelet-Rich Plasma*
Humans ; Female ; Male ; Treatment Outcome ; Pilot Projects ; Stromal Vascular Fraction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs-double whammy?
Autorzy:
Gupta A; Massachusetts General Hospital, Boston, Massachusetts, USA.
Kedia S; All India Institute of Medical Sciences, New Delhi, India.
Ahuja V; All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 815-816.
Typ publikacji:
Letter; Comment
MeSH Terms:
Crohn Disease*/diagnosis
Crohn Disease*/drug therapy
Humans ; Developing Countries ; Double-Blind Method
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of malnutrition and nutrition support in hospitalised patients with inflammatory bowel disease.
Autorzy:
Dua A; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Corson M; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Sauk JS; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Jaffe N; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Limketkai BN; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 897-906. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/therapy
Malnutrition*/epidemiology
Malnutrition*/therapy
Malnutrition*/complications
Crohn Disease*/complications
Crohn Disease*/therapy
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/therapy
Humans ; Health Care Costs
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease.
Autorzy:
Regev S; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Schwartz D; Department of Gastroenterology and Hepatology, Soroka Medical Center, Beer-Sheva, Israel.
Sarid O; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Goren G; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Slonim-Nevo V; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Friger M; Department of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Sergienko R; Department of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Greenberg D; Department of Health Systems Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Monsonego A; Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Nemirovsky A; Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Odes S; Division of Clinical Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 861-871. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Crohn Disease*/complications
Crohn Disease*/drug therapy
Humans ; Female ; Male ; Psychosocial Intervention ; Abdominal Pain/drug therapy ; Abdominal Pain/etiology ; Fatigue/etiology ; Fatigue/therapy ; Israel ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
Autorzy:
Peyrin-Biroulet L; Department of Gastroenterology, University of Lorraine, CHRU-Nancy, Nancy, France.; University of Lorraine, Inserm, NGERE, Nancy, France.
Ghosh S; APC Microbiome Ireland, University College Cork, Cork, Ireland.
Lee SD; University of Washington, Seattle, Washington, USA.
Lee WJ; AbbVie Inc., North Chicago, Illinois, USA.
Griffith J; AbbVie Inc., North Chicago, Illinois, USA.
Wallace K; AbbVie Inc., North Chicago, Illinois, USA.
Berg S; AbbVie Inc., North Chicago, Illinois, USA.
Liao X; AbbVie Inc., North Chicago, Illinois, USA.
Panes J; Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Loftus EV Jr; Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Louis E; University Hospital CHU of Liège, Liège, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 496-508. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Crohn Disease*/drug therapy
Crohn Disease*/chemically induced
Inflammatory Bowel Diseases*/drug therapy
Humans ; Quality of Life ; Antibodies, Monoclonal/adverse effects ; Fatigue/chemically induced ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study.
Autorzy:
Chen J; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.; Centre for Global Health, Zhejiang University School of Medicine, Hangzhou, China.; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Ruan X; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Yuan S; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Deng M; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Zhang H; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Sun J; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yu L; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Larsson SC; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Therdoratou E; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Wang X; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Li X; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (4), pp. 399-408. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antioxidants*/analysis
Colitis, Ulcerative*/blood
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/genetics
Crohn Disease*/blood
Crohn Disease*/complications
Crohn Disease*/genetics
Vitamins*/blood
Elements*
Humans ; Calcium ; Folic Acid ; Lycopene ; Magnesium ; Mendelian Randomization Analysis ; Phosphorus ; Selenium ; Vitamin A ; Vitamin K ; Zinc
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
Autorzy:
Jayasooriya N; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Baillie S; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Blackwell J; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Bottle A; School of Public Health, Imperial College London, London, UK.
Petersen I; Department of Primary Care and Population Health, University College London, London, UK.; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
Creese H; School of Public Health, Imperial College London, London, UK.
Saxena S; School of Public Health, Imperial College London, London, UK.
Pollok RC; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Pokaż więcej
Corporate Authors:
POP-IBD study group
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 635-652. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Colitis, Ulcerative*/diagnosis
Crohn Disease*/diagnosis
Inflammatory Bowel Diseases*/diagnosis
Humans ; Colectomy ; Delayed Diagnosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease.
Autorzy:
Din S; Edinburgh Inflammatory Bowel Diseases Unit, Western General Hospital, Edinburgh, UK.
Selinger CP; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
Black CJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 666-675. Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Crohn Disease*
Herpes Zoster*/epidemiology
Inflammatory Bowel Diseases*/drug therapy
Janus Kinase Inhibitors*/therapeutic use
Humans ; Biological Therapy ; Network Meta-Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sleep duration and daytime napping in relation to incident inflammatory bowel disease: a prospective cohort study.
Autorzy:
Yuan S; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Sun Y; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
Tan X; Unit of Functional Pharmacology and neuroscience, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Geng J; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
Sun J; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen X; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Yu L; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wang J; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Zhou X; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Hesketh T; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.; Institute for Global Health, University College London, London, UK.
Larsson SC; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Chen J; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Wang X; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Li X; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liu Z; Center for IBD Research, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 475-485. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Inflammatory Bowel Diseases*/epidemiology
Colitis, Ulcerative*/epidemiology
Crohn Disease*/epidemiology
Humans ; Prospective Studies ; Sleep Duration ; Incidence ; Sleep ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
Autorzy:
Fumery M; Department of Gastroenterology, Amiens University Hospital, and PeriTox, Université de Picardie, Amiens, France.
Defrance A; Groupe d'étude des Affections Inflammatoires du tube Digestif, GETAID, Paris, France.
Roblin X; Department of Gastroenterology, CHU of Saint-Etienne, Saint-Etienne, France.
Altwegg R; Department of Gastroenterology, CHU of Montpellier, Montpellier, France.
Caron B; Department of Gastroenterology and Inserm NGERE U1256, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Hébuterne X; Department of Gastroenterology and Clinical Nutrition, CHU of Nice and University Côte d'Azur, Nice, France.
Stefanescu C; Department of Gastroenterology, CHU Beaujon, APHP, Clichy, France.
Meyer A; Department of Gastroenterology, CHU Kremlin-Bicetre, APHP, Kremlin-Bicetre, France.
Nachury M; Department of Gastroenterology, CHU of Lille, Lille, France.
Laharie D; Service d'Hépato-Gastroentérologie et Oncologie Digestive, CHU de Bordeaux, Hôpital Haut-Lévêque, Université de Bordeaux, Bordeaux, France.
Nancey S; Department of Gastroenterology, CHU of Lyon, Lyon, France.
Le Berre C; Hépato-Gastro-Entérologie et Assistance Nutritionnelle, Inserm CIC 1413, Inserm UMR 1235, Institut des Maladies de l'Appareil Digestif (IMAD), Nantes Université, CHU Nantes, Nantes, France.
Serrero M; Department of Gastroenterology, CHU of Marseille, Marseille, France.
Geyl S; Department of Gastroenterology, CHU of Limoges, Limoges, France.
Giletta C; Department of Gastroenterology and Pancreatology, CHU of Toulouse RANGUEIL, Toulouse, France.
Ah-Soune P; Department of Gastroenterology, CH of Toulon, Toulon, France.
Duveau N; Department of Gastroenterology, CH of Roubaix, Roubaix, France.
Uzzan M; Gastroenterology Department, Henri Mondor Hospital, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France.
Abitbol V; Department of Gastroenterology, Hopital Cochin, Paris, France.
Biron A; Department of Gastroenterology, CHU of Reims, Reims, France.
Tran-Minh ML; Department of Gastroenterology, Hopital Saint-Louis, Paris, France.
Paupard T; Department of Gastroenterology, Centre Hospitalier de Dunkerque, Dunkirk, France.
Vuitton L; Department of Gastroenterology, UMR 1098, University of Franche-Comté, Besançon, France.
Elgharabawy Y; Groupe d'étude des Affections Inflammatoires du tube Digestif, GETAID, Paris, France.
Peyrin-Biroulet L; Department of Gastroenterology and Inserm NGERE U1256, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (4), pp. 426-434. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Crohn Disease*/therapy
Humans ; Ustekinumab/therapeutic use ; Induction Chemotherapy ; Retrospective Studies ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: shared decision-making intervention in patients with Crohn's disease-a personalised, patient-centred approach.
Autorzy:
Scribano ML; Villa Stuart Multi-Speciality Clinic, Rome, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jan; Vol. 57 (2), pp. 263-264.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Crohn Disease*/diagnosis
Crohn Disease*/therapy
Humans ; Decision Making
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study).
Autorzy:
Kulyk A; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; University of Manitoba IBD Clinical and Research Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Shafer LA; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; University of Manitoba IBD Clinical and Research Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Graff LA; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Stone J; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; University of Manitoba IBD Clinical and Research Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Witges K; University of Manitoba IBD Clinical and Research Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Targownik LE; University of Manitoba IBD Clinical and Research Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Bernstein CN; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; University of Manitoba IBD Clinical and Research Centre, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Dec; Vol. 56 (11-12), pp. 1570-1580. Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Crohn Disease*/diagnosis
Crohn Disease*/epidemiology
Inflammatory Bowel Diseases*/diagnosis
Male ; Female ; Humans ; Prospective Studies ; Manitoba/epidemiology ; Severity of Illness Index ; Diarrhea ; Fatigue
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial.
Autorzy:
Zisman-Ilani Y; Department of Social and Behavioral Sciences, College of Public Health, Temple University, Philadelphia, Pennsylvania, USA.; Department of Clinical, Educational and Health Psychology, Division of Psychology and Language Sciences, University College London, London, UK.
Thompson KD; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Siegel LS; Climate Interactive, Hanover, New Hampshire, USA.
Mackenzie T; Geisel School of Medicine at Dartmouth, Biomedical Data Science, Hanover, New Hampshire, USA.
Crate DJ; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Korzenik JR; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Melmed GY; Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Kozuch P; Inflammatory Bowel Disease Program, Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.
Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
Rubin DT; Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, Illinois, USA.
Regueiro MD; Cleveland Clinic, Cleveland, Ohio, USA.
Cross R; Department of Medicine, Division of Gastroenterology & Hepatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Wolf DC; Atlanta Gastroenterology Associates, Atlanta, Georgia, USA.
Hanson JS; Atrium Health Gastroenterology and Hepatology, Charlotte, North Carolina, USA.
Schwartz RM; MNGI Digestive Health, Minneapolis, Minnesota, USA.
Vrabie R; Gastroenterology Division, New York University, New York City, New York, USA.
Kreines MD; Gastro Health, Cincinnati, Ohio, USA.
Scherer T; Southern New Hampshire Health, Nashua, New Hampshire, USA.
Dubinsky MC; Department of Pediatrics, Susan and Leonard Feinstein IBD Center, Icahn School of Medicine Mount Sinai, New York City, New York, USA.
Siegel CA; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jan; Vol. 57 (2), pp. 205-214. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Crohn Disease*/drug therapy
Adult ; Humans ; Female ; Decision Making, Shared ; Decision Making
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alopecia areata induced by Adalimumab in a patient with Crohn's disease.
Autorzy:
Esposito G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Spennato S; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Guerriero L; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Ruggiero F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Patrì A; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Nastro F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15940. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Letter
MeSH Terms:
Crohn Disease*/drug therapy
Alopecia Areata*/chemically induced
Alopecia Areata*/diagnosis
Humans ; Adalimumab/adverse effects ; Tumor Necrosis Factor-alpha ; Treatment Outcome
SCR Disease Name:
Diffuse alopecia
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Autorzy:
Saifuddin A; London North West University Healthcare NHS Trust, London, UK.
Kent AJ; Department of Gastroenterology, King's College Hospital NHS Foundation Trust, London, UK.
Mehta SJ; Department of Gastroenterology, Barts Health NHS Trust, London, UK.
Hicks LC; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Gonzalez HA; Department of Inflammatory Bowel Disease, Hull University Teaching Hospitals NHS Trust, Hull, UK.; Department of Gastroenterology, University of Hull, Hull, UK.
Segal JP; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Brookes MJ; Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK.
Subramanian S; Department of Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.; Department of Gastroenterology, University of Liverpool, Liverpool, UK.
Bhala N; Department of Gastrointestinal Medicine, Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Applied Health Research, Institute of Translational Medicine, University of Birmingham, Birmingham, UK.
Conley TE; Department of Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Patel KV; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.
Lamb CA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Walker GJ; Department of Gastroenterology, Torbay and South Devon NHS Foundation Trust, Torquay, UK.
Kennedy NA; Department of Inflammatory Bowel Disease, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
Sebastian S; Department of Inflammatory Bowel Disease, Hull University Teaching Hospitals NHS Trust, Hull, UK.; Department of Gastroenterology, University of Hull, Hull, UK.
Pokaż więcej
Corporate Authors:
PREPARE-IBD Collaborators
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Nov; Vol. 56 (10), pp. 1460-1474. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/complications
Crohn Disease*/epidemiology
Humans ; Pandemics ; Ustekinumab ; State Medicine ; Cohort Studies ; Adrenal Cortex Hormones/therapeutic use ; Prednisolone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study.
Autorzy:
Nørgård BM; Center for Clinical Epidemiology, Odense University Hospital, Odense C, Denmark.; Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
Friedman S; Center for Clinical Epidemiology, Odense University Hospital, Odense C, Denmark.; Center for Crohn's and Colitis, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kjeldsen J; Department of Medical Gastroenterology S, Odense University Hospital, Odense C, Denmark.; Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
Nielsen J; Center for Clinical Epidemiology, Odense University Hospital, Odense C, Denmark.; Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense C, Denmark.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Nov; Vol. 56 (9), pp. 1349-1360. Date of Electronic Publication: 2022 Aug 28.
Typ publikacji:
Journal Article
MeSH Terms:
Colitis, Ulcerative*
Crohn Disease*/drug therapy
Child ; Cohort Studies ; Fathers ; Female ; Humans ; Infant, Newborn ; Infant, Small for Gestational Age ; Male ; Mesalamine/adverse effects ; Paternal Exposure/adverse effects ; Pregnancy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics.
Autorzy:
Choi SY; Department of Pediatrics, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, South Korea.
Kim ES; Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jeon TY; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee YM; Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea.
Lee SM; Department of Radiology, Kyungpook National University School of Medicine, Daegu, South Korea.
Choe BH; Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, South Korea.
Choe YH; Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.
Kang B; Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, South Korea.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Oct; Vol. 56 (7), pp. 1146-1156. Date of Electronic Publication: 2022 Jul 23.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Biological Products*/therapeutic use
Crohn Disease*/diagnostic imaging
Crohn Disease*/drug therapy
Child ; Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Prospective Studies ; Severity of Illness Index ; Tumor Necrosis Factor Inhibitors ; Tumor Necrosis Factor-alpha ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Autorzy:
Everhov ÅH; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Clinical Epidemiology Division, Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden.
Erichsen R; Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.; Department of Surgery, Randers Regional Hospital, Randers, Denmark.
Järås J; Clinical Epidemiology Division, Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden.
Pedersen L; Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Halfvarson J; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Askling J; Clinical Epidemiology Division, Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden.
Ekbom A; Clinical Epidemiology Division, Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden.
Ludvigsson JF; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Pediatrics, Orebro University Hospital, Orebro, Sweden.; Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Medicine, Columbia University College of Physicians and Surgeons, New York City, New York, USA.
Sørensen HT; Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
Olén O; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Clinical Epidemiology Division, Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden.; Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Oct; Vol. 56 (7), pp. 1168-1182. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/etiology
Crohn Disease*/complications
Crohn Disease*/diagnosis
Crohn Disease*/epidemiology
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/pathology
Aged ; Cohort Studies ; Humans ; Incidence ; Middle Aged ; Registries ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast.
Autorzy:
Agud-Dios M; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Arroyo-Andrés J; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Rubio-Muñiz C; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Postigo-Lorente C; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Oct; Vol. 35 (10), pp. e15743. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Letter
MeSH Terms:
Crohn Disease*/complications
Crohn Disease*/diagnosis
Crohn Disease*/drug therapy
Hidradenitis Suppurativa*/diagnosis
Hidradenitis Suppurativa*/drug therapy
Antibodies, Monoclonal, Humanized ; Humans ; Thalidomide/analogs & derivatives ; Thalidomide/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.
Autorzy:
Faye AS; Division of Gastroenterology, NYU Grossman School of Medicine, New York, New York, USA.
Lee KE; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Dodson J; Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Chodosh J; Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Hudesman D; Division of Gastroenterology, NYU Grossman School of Medicine, New York, New York, USA.
Remzi F; Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.
Wright JD; Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York, USA.
Friedman AM; Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York, USA.
Shaukat A; Division of Gastroenterology, NYU Grossman School of Medicine, New York, New York, USA.
Wen T; Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York, USA.; Department of Obstetrics and Gynecology, University of California San Francisco School of Medicine, San Francisco, California, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Oct; Vol. 56 (7), pp. 1157-1167. Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/epidemiology
Crohn Disease*/complications
Crohn Disease*/epidemiology
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/epidemiology
Pulmonary Embolism*
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Chronic Disease ; Humans ; Male ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1063

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies